ADC Therapeutics SA
ADCT
$3.10
-$0.01-0.32%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.74% | -25.63% | 30.12% | -20.32% | 21.59% |
| Total Depreciation and Amortization | 4.87% | 1.01% | -1.12% | -4.30% | -0.59% |
| Total Amortization of Deferred Charges | 240.31% | 134.29% | -207.95% | 17.27% | -12.52% |
| Total Other Non-Cash Items | 45.70% | 877.45% | -115.31% | 25.23% | -34.70% |
| Change in Net Operating Assets | 152.00% | -394.36% | 17.40% | 277.24% | 51.44% |
| Cash from Operations | 57.24% | -157.80% | 12.74% | 23.75% | 25.51% |
| Capital Expenditure | 100.00% | -193.33% | 58.33% | -620.00% | 94.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -193.33% | 58.33% | -620.00% | 94.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34,598.52% | 530.23% | -- | -- | 27,623.88% |
| Repurchase of Common Stock | -- | -- | -32.31% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 34,506.27% | 124.20% | -27.42% | -100.89% | 27,623.88% |
| Foreign Exchange rate Adjustments | 1.24% | 146.94% | -217.87% | 2,325.00% | 127.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 224.38% | -139.97% | 9.45% | -139.26% | 248.57% |